OTCMKTS:BIOTU

Biotech Acquisition Competitors

$10.06

+0.06 (+0.60 %)

(As of 04/9/2021 12:00 AM ET)

Add

Compare

Today's Range

$10.01

Now: $10.06▼

$10.08

50-Day Range

$9.89

MA: $10.16▼

$10.70

52-Week Range

$9.79

Now: $10.06▼

$10.95

Volume30,559 shs

Average Volume119,772 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Biotech Acquisition (OTCMKTS:BIOTU) Vs. SCCB, ACEVU, ACKIU, ADRAU, ADEXU, and IMPXU

Should you be buying BIOTU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to Biotech Acquisition, including 378 (SCCB), ACE Convergence Acquisition (ACEVU), Ackrell SPAC Partners I (ACKIU), Adara Acquisition (ADRAU), Adit EdTech Acquisition (ADEXU), and AEA-Bridges Impact (IMPXU).

Biotech Acquisition vs. 378 Stock

378 (OTCMKTS:SCCB) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for 378 and Biotech Acquisition, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
378	0	0	0	0	N/A
Biotech Acquisition	0	0	0	0	N/A

Profitability

This table compares 378 and Biotech Acquisition's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
378	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A

Valuation & Earnings

This table compares 378 and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
378	N/A	N/A	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A

Biotech Acquisition vs. ACE Convergence Acquisition Stock

ACE Convergence Acquisition (OTCMKTS:ACEVU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for ACE Convergence Acquisition and Biotech Acquisition, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ACE Convergence Acquisition	0	0	0	0	N/A
Biotech Acquisition	0	0	0	0	N/A

Profitability

This table compares ACE Convergence Acquisition and Biotech Acquisition's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ACE Convergence Acquisition	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A

Valuation & Earnings

This table compares ACE Convergence Acquisition and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ACE Convergence Acquisition	N/A	N/A	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A

Biotech Acquisition vs. Ackrell SPAC Partners I Stock

Ackrell SPAC Partners I (OTCMKTS:ACKIU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for Ackrell SPAC Partners I and Biotech Acquisition, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ackrell SPAC Partners I	0	0	0	0	N/A
Biotech Acquisition	0	0	0	0	N/A

Profitability

This table compares Ackrell SPAC Partners I and Biotech Acquisition's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ackrell SPAC Partners I	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A

Valuation & Earnings

This table compares Ackrell SPAC Partners I and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ackrell SPAC Partners I	N/A	N/A	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A

Biotech Acquisition vs. Adara Acquisition Stock

Adara Acquisition (OTCMKTS:ADRAU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for Adara Acquisition and Biotech Acquisition, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adara Acquisition	0	0	0	0	N/A
Biotech Acquisition	0	0	0	0	N/A

Valuation & Earnings

This table compares Adara Acquisition and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adara Acquisition	N/A	N/A	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Adara Acquisition and Biotech Acquisition's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adara Acquisition	N/A	N/A	N/A
Biotech Acquisition	N/A	N/A	N/A

Biotech Acquisition vs. Adit EdTech Acquisition Stock

Biotech Acquisition (OTCMKTS:BIOTU) and Adit EdTech Acquisition (OTCMKTS:ADEXU) are both -- companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Biotech Acquisition and Adit EdTech Acquisition, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotech Acquisition	0	0	0	0	N/A
Adit EdTech Acquisition	0	0	0	0	N/A

Earnings & Valuation

This table compares Biotech Acquisition and Adit EdTech Acquisition's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A
Adit EdTech Acquisition	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Biotech Acquisition and Adit EdTech Acquisition's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotech Acquisition	N/A	N/A	N/A
Adit EdTech Acquisition	N/A	N/A	N/A

Biotech Acquisition vs. AEA-Bridges Impact Stock

Biotech Acquisition (OTCMKTS:BIOTU) and AEA-Bridges Impact (OTCMKTS:IMPXU) are both -- companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Biotech Acquisition and AEA-Bridges Impact, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotech Acquisition	0	0	0	0	N/A
AEA-Bridges Impact	0	0	0	0	N/A

Earnings & Valuation

This table compares Biotech Acquisition and AEA-Bridges Impact's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotech Acquisition	N/A	N/A	N/A	N/A	N/A
AEA-Bridges Impact	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Biotech Acquisition and AEA-Bridges Impact's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotech Acquisition	N/A	N/A	N/A
AEA-Bridges Impact	N/A	N/A	N/A